[1]
2020. Assessment of MR-ProADM and N-Terminal B-Type Natriuretic Peptide of Serum Levels in Patients with Heart Failure. Medico Legal Update. 20, 3 (Jul. 2020), 621–626. DOI:https://doi.org/10.37506/mlu.v20i3.1469.